Education
About Us
Working with TipRanks
Follow Us
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
ASBP Stock Chart & Stats
$0.34
--
Market closed
$0.34
--
Day’s Range― - ―
52-Week Range$0.20 - $15.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)27.58M
Market Cap
$16.86M
Enterprise ValueN/A
Total Cash (Recent Filing)$206.23K
Total Debt (Recent Filing)$8.47M
Price to Earnings (P/E)―
Beta1.93
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.56
Shares Outstanding49,525,970
10 Day Avg. Volume3,584,512
30 Day Avg. Volume27,577,381
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-61.61
Price to Sales (P/S)0.00
P/FCF Ratio-357.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aspire Biopharma Holdings News
ASBP FAQ
What was Aspire Biopharma Holdings’s price range in the past 12 months?
Aspire Biopharma Holdings lowest stock price was $0.20 and its highest was $15.80 in the past 12 months.
What is Aspire Biopharma Holdings’s market cap?
Aspire Biopharma Holdings’s market cap is $16.86M.
When is Aspire Biopharma Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aspire Biopharma Holdings’s earnings last quarter?
Currently, no data Available
Is Aspire Biopharma Holdings overvalued?
According to Wall Street analysts Aspire Biopharma Holdings’s price is currently Overvalued.
Does Aspire Biopharma Holdings pay dividends?
Aspire Biopharma Holdings does not currently pay dividends.
What is Aspire Biopharma Holdings’s EPS estimate?
Aspire Biopharma Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aspire Biopharma Holdings have?
Aspire Biopharma Holdings has 49,525,970 shares outstanding.
What happened to Aspire Biopharma Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aspire Biopharma Holdings?
Currently, no hedge funds are holding shares in ASBP
Company Description
Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.
Technical Analysis
Biodexa Pharmaceuticals
―
―
Salarius Pharmaceuticals
―
Scinai Immunotherapeutics
―
Oragenics
―
Ownership Overview
0.04% Insiders
0.01% Mutual Funds
3.76% Other Institutional Investors
96.04% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---